CELSO
ARANGO LÓPEZ
Catedrático de universidad
Universidad de Cádiz
Cádiz, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Cádiz (11)
2021
-
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C
European Neuropsychopharmacology, Vol. 46, pp. 14-27
2019
-
Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model
European Neuropsychopharmacology, Vol. 29, Núm. 7, pp. 880-896
2018
-
The complex association between the antioxidant defense system and clinical status in early psychosis
PLoS ONE, Vol. 13, Núm. 4
2015
-
Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental
Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74
2014
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
2013
-
Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
International Journal of Neuropsychopharmacology, Vol. 16, Núm. 1, pp. 121-135
2012
-
Antioxidant defense system and family environment in adolescents with family history of psychosis
BMC Psychiatry, Vol. 12
-
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study
Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65
-
Plasma antioxidant capacity is reduced in Asperger syndrome
Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 394-401
2011
-
Reduced antioxidant defense in early onset first-episode psychosis: A case-control study
BMC Psychiatry, Vol. 11
2007
-
The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results
Schizophrenia Research, Vol. 91, Núm. 1-3, pp. 226-237